Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2001-6-14
pubmed:abstractText
Considering the role in the metabolism of chemicals played by biotransformation enzymes, we aimed at determining whether any association exists between genetic polymorphisms in CYP1A1, CYP2E1, epoxide hydrolase (EPHX), glutathione S-transferases (GSTM1/P1/T1) and individual susceptibility to lymphomas. PCR-RFLP-based genotyping assays were used to determine the frequency of polymorphisms in CYP1A1 (3'-flanking region), CYP2E1 (5'-flanking region and intron 6), EPHX (exons 3 and 4), GSTM1 (deletion), GSTP1 (exon 5) and GSTT1 (deletion) in a case-control study comprised of 219 patients with morbus Hodgkin (MH) and non-Hodgkin's lymphomas (NHL) and 455 age- and sex-matched healthy individuals. The distribution of genotypes in CYP2E1-intron 6 was significantly different between the control group and all lymphomas (P = 0.03), patients with NHL (P = 0.024), and especially aggressive diffuse NHL (P = 0.007). Grading of NHL seemed to be associated with this polymorphism as well (P = 0.041). The EPHX-exon 3 genotype distribution was significantly different between control males and males with all lymphomas (P = 0.01) or with NHL (P = 0.019). The Val/Val genotype of GSTP1-exon 5 was prevalent in all MH [odds ratio (OR) = 2.08, 95% confidence interval (CI) = 1.05-4.14] and this difference was particularly evident in females (OR = 2.97, 95% CI = 1.16-7.61). A significant difference in the distribution of GSTP1-exon 5 genotypes was found between NHL tumors >5 cm and those <5 cm (P = 0.03). The results suggest that genetic polymorphisms of biotransformation enzymes may play a significant role in the development of lymphoid malignancies.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0964-6906
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1265-73
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:11406608-Alleles, pubmed-meshheading:11406608-Biotransformation, pubmed-meshheading:11406608-Case-Control Studies, pubmed-meshheading:11406608-Cytochrome P-450 CYP1A1, pubmed-meshheading:11406608-Cytochrome P-450 CYP2E1, pubmed-meshheading:11406608-Cytochrome P-450 Enzyme System, pubmed-meshheading:11406608-Epoxide Hydrolases, pubmed-meshheading:11406608-Exons, pubmed-meshheading:11406608-Female, pubmed-meshheading:11406608-Genetic Predisposition to Disease, pubmed-meshheading:11406608-Genotype, pubmed-meshheading:11406608-Glutathione Transferase, pubmed-meshheading:11406608-Hodgkin Disease, pubmed-meshheading:11406608-Humans, pubmed-meshheading:11406608-Lymphoma, Non-Hodgkin, pubmed-meshheading:11406608-Male, pubmed-meshheading:11406608-Middle Aged, pubmed-meshheading:11406608-Polymorphism, Genetic
pubmed:year
2001
pubmed:articleTitle
Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas.
pubmed:affiliation
Biotransformations Group, Center of Occupational Diseases, National Institute of Public Health, Srobárova 48, Praha 10, 100 42, Czech Republic,.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't